Skip to main content
Top
Published in: Supportive Care in Cancer 8/2017

01-08-2017 | Original Article

The use of a patient-reported outcome questionnaire to assess cancer survivorship concerns and psychosocial outcomes among recent survivors

Authors: Steven C. Palmer, Carrie T. Stricker, Angela M. DeMichele, Marilyn Schapira, Karen Glanz, Jennifer J. Griggs, Linda A. Jacobs

Published in: Supportive Care in Cancer | Issue 8/2017

Login to get access

Abstract

Purpose

Survivor distress is well represented in the literature, but less is known about survivors’ concerns and how these relate to adaptation. Using a newly designed Survivorship Concern Scale, we examined concerns and their relationship to psychosocial adaptation among recent breast cancer (BC) survivors.

Methods

One hundred forty-three stage 0–III BC survivors completed an online assessment including the Survivorship Concern Scale (0–3 scale; alpha = 0.91), unmet needs, quality of life (QoL), and anxiety and depressive symptoms within 1 year of end of treatment.

Results

Participants were predominately white (76%), middle-aged (51 years), married (70%), and college educated (79%). Eighty-two percent were stage I or II at diagnosis. Mean degree of survivorship concern was moderate (M = 1.75, SD = 0.70) though variable (range = 0.12–3.00). Survivorship concerns were not significantly related to disease, treatment, or demographic variables except income (p = 0.02). Degree of survivorship concern was significantly associated with all indices of psychosocial adaptation: unmet need (r = 0.50), physical and mental QoL (r = −0.32 and r = −0.32, respectively), depressive symptoms (r = 0.21), and anxiety symptoms (r = 0.51; all p < 0.001). Binary logistic regression suggested that each one-point increase in degree of average concern increased the odds for elevated depressive symptoms by 2.83 (p = 0.03) and increased the odds of elevated anxiety symptoms by 3.69 (p < 0.001).

Conclusions

Survivorship concerns in the year following treatment are moderate but variable. Concerns are associated with QoL, unmet need, and psychosocial adaptation. Adequately addressing concerns may be a way to improve psychosocial outcomes early in the survivorship trajectory.
Footnotes
1
In initial analyses, we found income to relate significantly to both levels of survivor concerns and depressive symptoms, unmet need, and physical health component of the QoL measure. We reanalyzed these relationships controlling for income level and found no differences in outcome from the non-adjusted data, with the exception of the physical functioning subscale which was attenuated; therefore, the non-adjusted data is presented for ease of interpretation. No other demographic, disease, or treatment variables were associated with survivorship concerns (all p > 0.10).
 
Literature
1.
go back to reference American Cancer Society (2015) Breast cancer facts & figures 2015–2016. Atlanta: American Cancer Society, Inc. American Cancer Society (2015) Breast cancer facts & figures 2015–2016. Atlanta: American Cancer Society, Inc.
2.
go back to reference Miller KD, Siegel RL, Lin CC et al (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271–289CrossRefPubMed Miller KD, Siegel RL, Lin CC et al (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271–289CrossRefPubMed
3.
go back to reference Kenyon M, Mayer DK, Owens AK (2014) Late and long-term effects of breast cancer treatment and surveillance management for the general practitioner. J Obstet Gynecol Neonatal Nurs 43(3):382–398CrossRefPubMed Kenyon M, Mayer DK, Owens AK (2014) Late and long-term effects of breast cancer treatment and surveillance management for the general practitioner. J Obstet Gynecol Neonatal Nurs 43(3):382–398CrossRefPubMed
4.
go back to reference Hill DA, Horick NK, Isaacs C et al (2014) Long-term risk of medical conditions associated with breast cancer treatment. Breast Cancer Res Treat 145(1):233–243CrossRefPubMedPubMedCentral Hill DA, Horick NK, Isaacs C et al (2014) Long-term risk of medical conditions associated with breast cancer treatment. Breast Cancer Res Treat 145(1):233–243CrossRefPubMedPubMedCentral
5.
go back to reference Akechi T, Uchida M, Nakaguchi T et al (2015) Difference of patient’s perceived need in breast cancer patients after diagnosis. Jpn J Clin Oncol 45(1):75–80CrossRefPubMed Akechi T, Uchida M, Nakaguchi T et al (2015) Difference of patient’s perceived need in breast cancer patients after diagnosis. Jpn J Clin Oncol 45(1):75–80CrossRefPubMed
6.
go back to reference Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV (2005) Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer 41(17):2613–2619CrossRefPubMed Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV (2005) Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer 41(17):2613–2619CrossRefPubMed
7.
go back to reference Hsu T, Ennis M, Hood N, Graham M, Goodwin PJ (2013) Quality of life in long-term breast cancer survivors. J Clin Oncol 31(28):3540–3548CrossRefPubMed Hsu T, Ennis M, Hood N, Graham M, Goodwin PJ (2013) Quality of life in long-term breast cancer survivors. J Clin Oncol 31(28):3540–3548CrossRefPubMed
8.
go back to reference Koch L, Jansen L, Herrmann A et al (2013) Quality of life in long-term breast cancer survivors—a 10-year longitudinal population-based study. Acta Oncol 52(6):1119–1128CrossRefPubMed Koch L, Jansen L, Herrmann A et al (2013) Quality of life in long-term breast cancer survivors—a 10-year longitudinal population-based study. Acta Oncol 52(6):1119–1128CrossRefPubMed
9.
go back to reference Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P (2013) Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol 14(8):721–732CrossRefPubMed Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P (2013) Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol 14(8):721–732CrossRefPubMed
10.
go back to reference Koch L, Bertram H, Eberle A et al (2014) Fear of recurrence in long-term breast cancer survivors—still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship—a multi-regional population-based study. Psychooncology 23(5):547–554CrossRefPubMed Koch L, Bertram H, Eberle A et al (2014) Fear of recurrence in long-term breast cancer survivors—still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship—a multi-regional population-based study. Psychooncology 23(5):547–554CrossRefPubMed
11.
go back to reference Simard S, Thewes B, Humphris G et al (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7(3):300–322CrossRefPubMed Simard S, Thewes B, Humphris G et al (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7(3):300–322CrossRefPubMed
12.
go back to reference Paul C, Sanson-Fisher R, Carey M (2013) Measuring psychosocial outcomes: is the consumer or the professional the best judge? Eur J Cancer Care (Engl) 22(3):281–288CrossRef Paul C, Sanson-Fisher R, Carey M (2013) Measuring psychosocial outcomes: is the consumer or the professional the best judge? Eur J Cancer Care (Engl) 22(3):281–288CrossRef
13.
go back to reference Sanson-Fisher R, Carey M, Paul C (2009) Measuring the unmet needs of those with cancer: a critical overview. Cancer Forum 33 Sanson-Fisher R, Carey M, Paul C (2009) Measuring the unmet needs of those with cancer: a critical overview. Cancer Forum 33
14.
go back to reference Guidance for Industry Patient-Reported Outcome Measures (2009) Use in medical product development to support labeling claims. Department of Health and Human Services Food and Drug Administration, Silver Spring, Maryland: U.S Guidance for Industry Patient-Reported Outcome Measures (2009) Use in medical product development to support labeling claims. Department of Health and Human Services Food and Drug Administration, Silver Spring, Maryland: U.S
15.
go back to reference Chen J, Ou L, Hollis SJ (2013) A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res 13:211CrossRefPubMedPubMedCentral Chen J, Ou L, Hollis SJ (2013) A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res 13:211CrossRefPubMedPubMedCentral
16.
go back to reference Kotronoulas G, Kearney N, Maguire R et al (2014) What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol 32(14):1480–1501CrossRefPubMed Kotronoulas G, Kearney N, Maguire R et al (2014) What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol 32(14):1480–1501CrossRefPubMed
17.
go back to reference Tzelepis F, Sanson-Fisher RW, Zucca AC, Fradgley EA (2015) Measuring the quality of patient-centered care: why patient-reported measures are critical to reliable assessment. Patient Prefer Adherence 9:831–835CrossRefPubMedPubMedCentral Tzelepis F, Sanson-Fisher RW, Zucca AC, Fradgley EA (2015) Measuring the quality of patient-centered care: why patient-reported measures are critical to reliable assessment. Patient Prefer Adherence 9:831–835CrossRefPubMedPubMedCentral
18.
go back to reference Adler-Milstein J, DesRoches CM, Kralovec P et al (2015) Electronic health record adoption in US hospitals: progress continues, but challenges persist. Health Aff (Millwood) 34(12):2174–2180CrossRef Adler-Milstein J, DesRoches CM, Kralovec P et al (2015) Electronic health record adoption in US hospitals: progress continues, but challenges persist. Health Aff (Millwood) 34(12):2174–2180CrossRef
19.
go back to reference Berry DA, Cronin KA, Plevritis SK et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353(17):1784–1792CrossRefPubMed Berry DA, Cronin KA, Plevritis SK et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353(17):1784–1792CrossRefPubMed
20.
go back to reference Allen JD, Savadatti S, Levy AG (2009) The transition from breast cancer ‘patient’ to ‘survivor’. Psychooncology 18(1):71–78CrossRefPubMed Allen JD, Savadatti S, Levy AG (2009) The transition from breast cancer ‘patient’ to ‘survivor’. Psychooncology 18(1):71–78CrossRefPubMed
21.
go back to reference Griggs JJ, Sorbero ME, Mallinger JB et al (2007) Vitality, mental health, and satisfaction with information after breast cancer. Patient Educ Couns 66(1):58–66CrossRefPubMed Griggs JJ, Sorbero ME, Mallinger JB et al (2007) Vitality, mental health, and satisfaction with information after breast cancer. Patient Educ Couns 66(1):58–66CrossRefPubMed
22.
go back to reference Palmer SC, Vaughn DJ, Blauch AN, Pucci DA, Jacobs LA (2017) Patient-reported outcomes (PROs) in testicular cancer survivors (TCS): do unmet needs resolve with routine care?. Paper presented at: 2017 ASCO Quality Care Symposium2017; Orlando, FL Palmer SC, Vaughn DJ, Blauch AN, Pucci DA, Jacobs LA (2017) Patient-reported outcomes (PROs) in testicular cancer survivors (TCS): do unmet needs resolve with routine care?. Paper presented at: 2017 ASCO Quality Care Symposium2017; Orlando, FL
23.
go back to reference Palmer S, DeMichele A, Schapira M et al (2016) Symptoms, unmet need, and quality of life among recent breast cancer survivors. JCSO 14(7):2–9CrossRef Palmer S, DeMichele A, Schapira M et al (2016) Symptoms, unmet need, and quality of life among recent breast cancer survivors. JCSO 14(7):2–9CrossRef
24.
go back to reference Ware JE, Jr., Kosinisk M, Turner-Bowker DM, Gandek B (2002) User’s manual for the SF-12v2® health survey with a supplement documenting SF-12® health survey. Lincoln, RI: QualityMetric Incorporated Ware JE, Jr., Kosinisk M, Turner-Bowker DM, Gandek B (2002) User’s manual for the SF-12v2® health survey with a supplement documenting SF-12® health survey. Lincoln, RI: QualityMetric Incorporated
25.
go back to reference Kazis L. The veterans SF-36 health status questionnaire: development and application in the veterans health administration. Med Outcomes Trust Monitor. 2000;5(1) Kazis L. The veterans SF-36 health status questionnaire: development and application in the veterans health administration. Med Outcomes Trust Monitor. 2000;5(1)
26.
go back to reference Zigmond AS, Snaith RP (Jun 1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed Zigmond AS, Snaith RP (Jun 1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed
27.
go back to reference Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52(2):69–77CrossRefPubMed Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52(2):69–77CrossRefPubMed
28.
go back to reference Ewertz M, Jensen AB (Feb 2011) Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol 50(2):187–193CrossRefPubMed Ewertz M, Jensen AB (Feb 2011) Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol 50(2):187–193CrossRefPubMed
29.
go back to reference Fallowfield L, Jenkins V (2014) Psychosocial/survivorship issues in breast cancer: are we doing better? J Natl Cancer Inst 107(1):335CrossRefPubMed Fallowfield L, Jenkins V (2014) Psychosocial/survivorship issues in breast cancer: are we doing better? J Natl Cancer Inst 107(1):335CrossRefPubMed
30.
go back to reference Farrell C, Heaven C, Beaver K, Maguire P (2005) Identifying the concerns of women undergoing chemotherapy. Patient Educ Couns 56(1):72–77CrossRefPubMed Farrell C, Heaven C, Beaver K, Maguire P (2005) Identifying the concerns of women undergoing chemotherapy. Patient Educ Couns 56(1):72–77CrossRefPubMed
31.
go back to reference Bazzell JL, Spurlock A, McBride M (2015) Matching the unmet needs of cancer survivors to resources using a shared care model. J Cancer Educ 30(2):312–318CrossRefPubMed Bazzell JL, Spurlock A, McBride M (2015) Matching the unmet needs of cancer survivors to resources using a shared care model. J Cancer Educ 30(2):312–318CrossRefPubMed
32.
go back to reference Treanor C, Santin O, Mills M, Donnelly M (2013) Cancer survivors with self-reported late effects: their health status, care needs and service utilisation. Psychooncology 22(11):2428–2435CrossRefPubMed Treanor C, Santin O, Mills M, Donnelly M (2013) Cancer survivors with self-reported late effects: their health status, care needs and service utilisation. Psychooncology 22(11):2428–2435CrossRefPubMed
33.
go back to reference Mao JJ, Bowman MA, Stricker CT et al (2009) Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol 27(6):933–938CrossRefPubMed Mao JJ, Bowman MA, Stricker CT et al (2009) Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol 27(6):933–938CrossRefPubMed
34.
go back to reference Burg MA, Adorno G, Lopez ED et al (2015) Current unmet needs of cancer survivors: analysis of open-ended responses to the American Cancer Society Study of Cancer Survivors II. Cancer 121(4):623–630CrossRefPubMed Burg MA, Adorno G, Lopez ED et al (2015) Current unmet needs of cancer survivors: analysis of open-ended responses to the American Cancer Society Study of Cancer Survivors II. Cancer 121(4):623–630CrossRefPubMed
35.
go back to reference Ruland CM, Andersen T, Jeneson A et al (2013) Effects of an internet support system to assist cancer patients in reducing symptom distress: a randomized controlled trial. Cancer Nurs 36(1):6–17CrossRefPubMed Ruland CM, Andersen T, Jeneson A et al (2013) Effects of an internet support system to assist cancer patients in reducing symptom distress: a randomized controlled trial. Cancer Nurs 36(1):6–17CrossRefPubMed
36.
go back to reference Borosund E, Cvancarova M, Moore SM, Ekstedt M, Ruland CM (2014) Comparing effects in regular practice of e-communication and web-based self-management support among breast cancer patients: preliminary results from a randomized controlled trial. J Med Internet Res 16(12):e295CrossRefPubMedPubMedCentral Borosund E, Cvancarova M, Moore SM, Ekstedt M, Ruland CM (2014) Comparing effects in regular practice of e-communication and web-based self-management support among breast cancer patients: preliminary results from a randomized controlled trial. J Med Internet Res 16(12):e295CrossRefPubMedPubMedCentral
37.
go back to reference Kadakia KC, Snyder CF, Kidwell KM et al (2016) Patient-reported outcomes and early discontinuation in aromatase inhibitor-treated postmenopausal women with early stage breast cancer. Oncologist 21(5):539–546CrossRefPubMedPubMedCentral Kadakia KC, Snyder CF, Kidwell KM et al (2016) Patient-reported outcomes and early discontinuation in aromatase inhibitor-treated postmenopausal women with early stage breast cancer. Oncologist 21(5):539–546CrossRefPubMedPubMedCentral
38.
go back to reference Husson O, Mols F, van de Poll-Franse LV (2011) The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. Ann Oncol 22(4):761–772CrossRefPubMed Husson O, Mols F, van de Poll-Franse LV (2011) The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. Ann Oncol 22(4):761–772CrossRefPubMed
39.
go back to reference Janz NK, Li Y, Beesley LJ, et al. (2016) Worry about recurrence in a multi-ethnic population of breast cancer survivors and their partners. Support Care Cancer Janz NK, Li Y, Beesley LJ, et al. (2016) Worry about recurrence in a multi-ethnic population of breast cancer survivors and their partners. Support Care Cancer
40.
go back to reference Calhoun C, Helzlsouer KJ, Gallicchio L (2015) Racial differences in depressive symptoms and self-rated health among breast cancer survivors on aromatase inhibitor therapy. J Psychosoc Oncol 33(3):263–277CrossRefPubMed Calhoun C, Helzlsouer KJ, Gallicchio L (2015) Racial differences in depressive symptoms and self-rated health among breast cancer survivors on aromatase inhibitor therapy. J Psychosoc Oncol 33(3):263–277CrossRefPubMed
41.
go back to reference Maly RC, Liu Y, Liang LJ, Ganz PA (2015) Quality of life over 5 years after a breast cancer diagnosis among low-income women: effects of race/ethnicity and patient-physician communication. Cancer 121(6):916–926CrossRefPubMed Maly RC, Liu Y, Liang LJ, Ganz PA (2015) Quality of life over 5 years after a breast cancer diagnosis among low-income women: effects of race/ethnicity and patient-physician communication. Cancer 121(6):916–926CrossRefPubMed
42.
go back to reference Barg FK, Cronholm PF, Straton JB et al (2007) Unmet psychosocial needs of Pennsylvanians with cancer: 1986-2005. Cancer 110(3):631–639CrossRefPubMed Barg FK, Cronholm PF, Straton JB et al (2007) Unmet psychosocial needs of Pennsylvanians with cancer: 1986-2005. Cancer 110(3):631–639CrossRefPubMed
43.
go back to reference Vodermaier A, Millman RD (2011) Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer 19(12):1899–1908CrossRefPubMed Vodermaier A, Millman RD (2011) Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer 19(12):1899–1908CrossRefPubMed
44.
go back to reference Boekhout AH, Maunsell E, Pond GR et al (2015) A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial. J Cancer Surviv 9(4):683–691CrossRefPubMed Boekhout AH, Maunsell E, Pond GR et al (2015) A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial. J Cancer Surviv 9(4):683–691CrossRefPubMed
45.
go back to reference Nicolaije KA, Ezendam NP, Vos MC et al (2015) Impact of an automatically generated cancer survivorship care plan on patient-reported outcomes in routine clinical practice: longitudinal outcomes of a pragmatic, cluster randomized trial. J Clin Oncol 33(31):3550–3559CrossRefPubMed Nicolaije KA, Ezendam NP, Vos MC et al (2015) Impact of an automatically generated cancer survivorship care plan on patient-reported outcomes in routine clinical practice: longitudinal outcomes of a pragmatic, cluster randomized trial. J Clin Oncol 33(31):3550–3559CrossRefPubMed
Metadata
Title
The use of a patient-reported outcome questionnaire to assess cancer survivorship concerns and psychosocial outcomes among recent survivors
Authors
Steven C. Palmer
Carrie T. Stricker
Angela M. DeMichele
Marilyn Schapira
Karen Glanz
Jennifer J. Griggs
Linda A. Jacobs
Publication date
01-08-2017
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 8/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3646-3

Other articles of this Issue 8/2017

Supportive Care in Cancer 8/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine